---
created: '2026-02-09T05:40:21.045343Z'
description: A progressive neurodegenerative disorder characterized by motor symptoms
  including tremor, rigidity, and bradykinesia, caused by dopaminergic neuron loss
  in the substantia nigra and alpha-synuclein aggregation.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/condition/parkinsons-disease/
slug: parkinsons-disease
tags:
- condition
- neurodegeneration
- movement-disorder
- dopamine
templateEngineOverride: njk
title: Parkinson's Disease
type: condition
updated: '2026-02-09T05:40:21.045343Z'
---

{% raw %}
<h1>Parkinson's Disease</h1>
<h2>Overview</h2>
<p>Parkinson's Disease (PD) is the second most common neurodegenerative disorder after Alzheimer's Disease. It primarily affects the dopaminergic neurons in the <strong>substantia nigra pars compacta</strong>, leading to motor dysfunction. The pathological hallmark is the presence of <strong>Lewy bodies</strong> containing aggregated <strong>alpha-synuclein</strong> protein.</p>
<h2>Cardinal Motor Symptoms</h2>
<ol>
<li><strong>Tremor</strong>: Resting tremor, typically &quot;pill-rolling&quot;</li>
<li><strong>Rigidity</strong>: Increased muscle tone, &quot;cogwheel&quot; rigidity</li>
<li><strong>Bradykinesia</strong>: Slowness of movement initiation and execution</li>
<li><strong>Postural Instability</strong>: Balance and gait disturbances (late stage)</li>
</ol>
<h2>Non-Motor Symptoms</h2>
<ul>
<li>REM sleep behavior disorder (often prodromal)</li>
<li>Anosmia (loss of smell)</li>
<li>Constipation and autonomic dysfunction</li>
<li>Depression and anxiety</li>
<li>Cognitive impairment progressing to dementia</li>
</ul>
<h2>Key Mechanisms</h2>
<ol>
<li><strong>Alpha-Synuclein Aggregation</strong>: Misfolded alpha-synuclein forms toxic oligomers and Lewy bodies</li>
<li><strong>Mitochondrial Dysfunction</strong>: Complex I deficiency and oxidative stress</li>
<li><strong>Neuroinflammation</strong>: Microglial activation and pro-inflammatory cytokines</li>
<li><strong>Impaired Proteostasis</strong>: Dysfunction in autophagy-lysosomal and ubiquitin-proteasome systems</li>
</ol>
<h2>Genetic Risk Factors</h2>
<ul>
<li><strong>SNCA</strong>: Encodes alpha-synuclein; duplications/triplications cause familial PD</li>
<li><strong>LRRK2</strong>: Most common cause of familial PD; kinase activity inhibitors in development</li>
<li><strong>GBA1</strong>: Glucocerebrosidase mutations; strongest genetic risk factor for sporadic PD</li>
<li><strong>PINK1/Parkin</strong>: Mitophagy pathway genes; early-onset PD</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>← [[Alpha-Synuclein_SAA]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:44.082636'
source: obsidian
</code></pre>
<ul>
<li>← [[DAT-SPECT]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:44.395203'
source: obsidian
</code></pre>
<ul>
<li>← [[Retinal_Imaging_for_Neurodegeneration]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:45.549973'
source: obsidian
</code></pre>
<ul>
<li>← [[Sleep_Optimization]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:48.863953'
source: obsidian
</code></pre>
<ul>
<li>← [[Amyloid-Beta_4240_Ratio]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:09.882854'
source: obsidian
</code></pre>
<ul>
<li>← [[BDNF]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.191066'
source: obsidian
</code></pre>
<ul>
<li>← [[Blood_NfL]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>← [[Digital_Biomarkers_for_Neurodegeneration]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:11.464163'
source: obsidian
</code></pre>
<ul>
<li>← [[Neurofilament_Light_Chain]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:15.198842'
source: obsidian
</code></pre>
<ul>
<li>← [[Neuron-Derived_Exosome_Biomarkers]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:15.353378'
source: obsidian
</code></pre>
<ul>
<li>← [[Alpha-Synuclein_Aggregation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>← [[Autophagy-Lysosomal_Pathway]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>← [[Neuroinflammation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:12.428247'
source: obsidian
</code></pre>
<ul>
<li>→ [[Autophagy-Lysosomal_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Parkinsons_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Locus_Coeruleus]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neurofilament_Light_Chain]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Nigrostriatal_Dopamine_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Substantia_Nigra]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Locus_Coeruleus]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Basal_Ganglia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Mitophagy]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Coenzyme_Q10]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Striatum]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Creatine]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[DAT-SPECT]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Levodopa]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Pramipexole]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Carbidopa]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Rasagiline]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_CSF]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_Aggregation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Deep_Brain_Stimulation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Omega-3_DHA]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neurofilament_Light_Chain]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neuroinflammation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Substantia_Nigra]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_CSF]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Retinal_Imaging_for_Neurodegeneration]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Digital_Biomarkers_for_Neurodegeneration]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Deep_Brain_Stimulation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Sleep_Optimization]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Basal_Ganglia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Nigrostriatal_Dopamine_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Blood_NfL]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Omega-3_DHA]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_SAA]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Coenzyme_Q10]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_Aggregation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neuron-Derived_Exosome_Biomarkers]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid-Beta_4240_Ratio]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[BDNF]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:49.397368'
source: obsidian
</code></pre>
<ul>
<li>→ [[Parkinsons_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:03:53.109152'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Affected Brain Regions</h3>
<ul>
<li>→ [[Substantia Nigra]] (organ) - <em>Primary site of dopaminergic neuron loss</em></li>
<li>→ [[Striatum]] (organ) - <em>Dopamine depletion target</em></li>
<li>→ [[Locus Coeruleus]] (organ) - <em>Noradrenergic degeneration</em></li>
<li>→ [[Basal Ganglia]] (organ) - <em>Motor circuit dysfunction</em></li>
</ul>
<h3>Associated Pathways</h3>
<ul>
<li>→ [[Nigrostriatal Dopamine Pathway]] (pathway) - <em>Primary affected pathway</em></li>
<li>→ [[Mitophagy]] (pathway) - <em>Impaired mitochondrial quality control</em></li>
<li>→ [[Alpha-Synuclein Aggregation]] (pathway) - <em>Core pathological process</em></li>
</ul>
<h3>Biomarkers</h3>
<ul>
<li>← [[Neurofilament Light Chain]] (biomarker) - <em>Marker of neurodegeneration</em></li>
<li>← [[Alpha-Synuclein CSF]] (biomarker) - <em>Diagnostic potential</em></li>
<li>← [[DAT-SPECT]] (examination) - <em>Dopamine transporter imaging</em></li>
</ul>
<h3>Treatments</h3>
<ul>
<li>← [[Levodopa]] (drug) - <em>Gold standard dopamine replacement</em></li>
<li>← [[Carbidopa]] (drug) - <em>Peripheral decarboxylase inhibitor</em></li>
<li>← [[Pramipexole]] (drug) - <em>Dopamine agonist</em></li>
<li>← [[Rasagiline]] (drug) - <em>MAO-B inhibitor</em></li>
<li>← [[Deep Brain Stimulation]] (intervention) - <em>Surgical treatment</em></li>
</ul>
<h3>Neuroprotective Supplements</h3>
<ul>
<li>← [[Coenzyme Q10]] (supplement) - <em>Mitochondrial support</em></li>
<li>← [[Creatine]] (supplement) - <em>Energy metabolism</em></li>
<li>← [[Omega-3 DHA]] (supplement) - <em>Anti-inflammatory</em></li>
</ul>
<h2>References</h2>
<ol>
<li><strong>Review</strong>: Bloem, B.R., et al. (2021). &quot;Parkinson's disease.&quot; <em>The Lancet</em>.</li>
<li><strong>Pathology</strong>: Spillantini, M.G., et al. (1997). &quot;Alpha-synuclein in Lewy bodies.&quot; <em>Nature</em>.</li>
</ol>

{% endraw %}